Evidence map›Paper›PMID 30059535›Full record

ArticlePLoS pathogens2018

Intersection of phosphate transport, oxidative stress and TOR signalling in Candida albicans virulence.

Ning-Ning Liu, Priya Uppuluri, Achille Broggi, Angelique Besold, Kicki Ryman, Hiroto Kambara, Norma Solis, Viola Lorenz, Wanjun Qi, Maikel Acosta-Zaldívar and 13 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Drug-resistant clinicalAntimicrobial agents and chemotherapy · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. A COmBio · 2024
    Article
  14. Article
  15. bioRxiv : the preprint server for biology · 2024
    Article
  16. Article
  17. The utility ofFrontiers in immunology · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 5 institutions in 4 countries.

Ning-Ning LiuDivision of Infectious Diseases, Boston Children's Hospital/Harvard Medical School, Boston, Massachusetts, United States of America.
Priya UppuluriDivision of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, United States of America.
Achille BroggiDivision of Gastroenterology, Boston Children's Hospital/Harvard Medical School, Boston, Massachusetts, United States of America.
Angelique BesoldDepartment of Biochemistry and Molecular Biology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Kicki RymanDepartment of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.
Hiroto KambaraDepartment of Pathology, Joint Program in Transfusion Medicine, Boston Children's Hospital/Harvard Medical School, Boston, Massachusetts, United States of America.
Norma SolisDivision of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, United States of America.
Viola LorenzDivision of Newborn Medicine, Boston Children's Hospital/Harvard Medical School, Boston, Massachusetts, United States of America.
Wanjun QiDivision of Infectious Diseases, Boston Children's Hospital/Harvard Medical School, Boston, Massachusetts, United States of America.ORCID 0000-0003-4593-5734
Maikel Acosta-ZaldívarDivision of Infectious Diseases, Boston Children's Hospital/Harvard Medical School, Boston, Massachusetts, United States of America.ORCID 0000-0002-9562-6887
S Noushin EmamiDepartment of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.ORCID 0000-0001-7239-4457
Bin BaoDivision of Infectious Diseases, Boston Children's Hospital/Harvard Medical School, Boston, Massachusetts, United States of America.
Dingding AnDivision of Infectious Diseases, Boston Children's Hospital/Harvard Medical School, Boston, Massachusetts, United States of America.
Francisco A BonillaClinical Immunology Program, Boston Children's Hospital, Boston, Massachusetts, United States of America.
Martha Sola-VisnerDivision of Newborn Medicine, Boston Children's Hospital/Harvard Medical School, Boston, Massachusetts, United States of America.ORCID 0000-0002-0013-598X
Scott G FillerDivision of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, United States of America.
Hongbo R LuoDepartment of Pathology, Joint Program in Transfusion Medicine, Boston Children's Hospital/Harvard Medical School, Boston, Massachusetts, United States of America.
Ylva EngströmDepartment of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.ORCID 0000-0002-8731-4613
Per Olof LjungdahlDepartment of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.ORCID 0000-0002-6625-3540
Valeria C CulottaDepartment of Biochemistry and Molecular Biology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Ivan ZanoniDivision of Gastroenterology, Boston Children's Hospital/Harvard Medical School, Boston, Massachusetts, United States of America.
Jose L Lopez-RibotDepartment of Biology, University of Texas at San Antonio, San Antonio, Texas, United States of America.
Julia R KöhlerDivision of Infectious Diseases, Boston Children's Hospital/Harvard Medical School, Boston, Massachusetts, United States of America.ORCID 0000-0003-3015-9015
Boston Children's Hospital · USStockholm University · SEThe Lundquist Institute · USJohns Hopkins University · USThe University of Texas at San Antonio · US

Funding

STRUCTURE-FUNCTION RELATIONSHIPS IN THE ALIMENTARY TRACTP30DK034854 · NIDDK · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI JONATHAN C KAGAN · 1986 to 2026
$32.4M
Transcription regulation in hematopoiesisP01HL095489 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI PARK, SHINYOUNG · 2010 to 2020
$20.1M
TRAINING IN AREAS FUNDAMENTAL TO CANCER RESEARCHT32CA009110 · NCI · JOHNS HOPKINS UNIVERSITY · PI MATUNIS, MICHAEL J., WEERARATNA, ASHANI T · 1985 to 2025
$13.1M
Type III interferon Control of Mucosal ImmunityR01DK115217 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI Scott B Snapper, Ivan Zanoni · 2017 to 2026
$5.6M
Enhancing neutrophil function in neutropenia-related pneumoniaR01HL092020 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI LUO, HONGBO R · 2009 to 2022
$5.2M
Innate control of the inflammatory process during fungal infectionsR01AI121066 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI ZANONI, IVAN · 2016 to 2025
$4.8M
C. albicans invasion and proliferation during oral infectionR01DE026600 · NIDCR · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI FILLER, SCOTT G, MITCHELL, AARON P · 2017 to 2021
$3.0M
Copper as a nutrient for Candida albicans at the host-pathogen interfaceR01AI119949 · NIAID · JOHNS HOPKINS UNIVERSITY · PI CULOTTA, VALERIA C · 2015 to 2019
$2.3M
Regulation of neutrophil function by ROS-induced actin glutathionylationR01AI103142 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI LUO, HONGBO R · 2014 to 2018
$2.2M
The opportunist Candida albicans: yeast proliferation and nutritional signalingR01AI095305 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI KOEHLER, JULIA R · 2013 to 2017
$2.2M
Role of Candida albicans phosphate transport in cell wall maintenance and echinocandin toleranceR21AI137716 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI KOEHLER, JULIA R · 2018 to 2019
$487k
Calprotectin and metal withholding during Candida albicans invasion of the kidneyF32AI124506 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BESOLD, ANGELIQUE NICOLE · 2016 to 2017
$114k
NHLBI NIH HHS P01 HL095489NHLBI NIH HHS R01 HL092020NIAID NIH HHS F32 AI124506NIAID NIH HHS R01 AI095305NIAID NIH HHS R01 AI103142NIAID NIH HHS R01 AI119949NIAID NIH HHS R01 AI121066NIAID NIH HHS R21 AI137716NIDCR NIH HHS R01 DE026600NIDDK NIH HHS P30 DK034854NIDDK NIH HHS R01 DK115217
6 · The paper itself

Abstract

Phosphate is an essential macronutrient required for cell growth and division. Pho84 is the major high-affinity cell-surface phosphate importer of Saccharomyces cerevisiae and a crucial element in the phosphate homeostatic system of this model yeast. We found that loss of Candida albicans Pho84 attenuated virulence in Drosophila and murine oropharyngeal and disseminated models of invasive infection, and conferred hypersensitivity to neutrophil killing. Susceptibility of cells lacking Pho84 to neutrophil attack depended on reactive oxygen species (ROS): pho84-/- cells were no more susceptible than wild type C. albicans to neutrophils from a patient with chronic granulomatous disease, or to those whose oxidative burst was pharmacologically inhibited or neutralized. pho84-/- mutants hyperactivated oxidative stress signalling. They accumulated intracellular ROS in the absence of extrinsic oxidative stress, in high as well as low ambient phosphate conditions. ROS accumulation correlated with diminished levels of the unique superoxide dismutase Sod3 in pho84-/- cells, while SOD3 overexpression from a conditional promoter substantially restored these cells' oxidative stress resistance in vitro. Repression of SOD3 expression sharply increased their oxidative stress hypersensitivity. Neither of these oxidative stress management effects of manipulating SOD3 transcription was observed in PHO84 wild type cells. Sod3 levels were not the only factor driving oxidative stress effects on pho84-/- cells, though, because overexpressing SOD3 did not ameliorate these cells' hypersensitivity to neutrophil killing ex vivo, indicating Pho84 has further roles in oxidative stress resistance and virulence. Measurement of cellular metal concentrations demonstrated that diminished Sod3 expression was not due to decreased import of its metal cofactor manganese, as predicted from the function of S. cerevisiae Pho84 as a low-affinity manganese transporter. Instead of a role of Pho84 in metal transport, we found its role in TORC1 activation to impact oxidative stress management: overexpression of the TORC1-activating GTPase Gtr1 relieved the Sod3 deficit and ROS excess in pho84-/- null mutant cells, though it did not suppress their hypersensitivity to neutrophil killing or hyphal growth defect. Pharmacologic inhibition of Pho84 by small molecules including the FDA-approved drug foscarnet also induced ROS accumulation. Inhibiting Pho84 could hence support host defenses by sensitizing C. albicans to oxidative stress.

Indexed as

AnimalsBiological TransportCandida albicansCandidiasisDrosophilaFungal ProteinsHumansMiceOxidative StressPhosphatesProton-Phosphate SymportersSignal TransductionTOR Serine-Threonine KinasesVirulenceFungal ProteinsPhosphatesProton-Phosphate SymportersTOR Serine-Threonine Kinases

Identifiers

PMID30059535
PMCPMC6085062
OpenAlexW2952433910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.